Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-18

FDA Approved: LAMIVUDINE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Lupin Pharmaceuticals' original application for lamivudine as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)

Snippet

ORIG AP for LAMIVUDINE (LAMIVUDINE)